Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H21F3N4O2 |
InChIKeyRESDVUQVZOJNSO-RWCBKNGVSA-N |
CAS Registry2820198-43-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Neoplasms | Preclinical | United States | 17 Apr 2023 |